By examining IL-17 signaling-related genes, IL-8, CCL2 levels, mTOR signaling and EIF2 signaling pathways genes, it is confirmed that BMSCs and leukemia cells both contribute to the creation of a competitive niche more favorable for leukemia stem cells [23]. The gene discussed is CCL2; the disease is leukemia.